The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Results on Rescue Use and Night-Time Awakenings

被引：0

作者：

Kaisermann, M. C. ^{[1
]}

Criner, G. J. ^{[2
]}

Dransfield, M. T. ^{[3
]}

Halpin, D. M. ^{[4
]}

Han, M. K. ^{[5
]}

Jones, C. E. ^{[6
]}

Kilbride, S. ^{[7
]}

Lange, P. ^{[8
]}

Lomas, D. A. ^{[9
]}

Martinez, F. J. ^{[10
]}

Pascoe, S. J. ^{[1
]}

Singh, D. ^{[11
]}

Wise, R. A. ^{[12
]}

Lipson, D. A. ^{[1
,13
]}

机构：

[1] GSK, Collegeville, PA USA

[2] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA

[3] Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA

[4] Royal Devon & Exeter Hosp, Dept Resp Med, Exeter, Devon, England

[5] Univ Michigan, Pulm & Crit Care, Ann Arbor, MI 48109 USA

[6] GSK, Res Triangle Pk, NC USA

[7] GSK, Uxbridge, Middx, England

[8] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark

[9] UCL, UCL Resp, London, England

[10] Weill Cornell Med, New York, NY USA

[11] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England

[12] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA

[13] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A3347

引用

页数：3

共 50 条

[1] The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Results on Cardiovascular Safety
Lipson, D. A.
Criner, G.
Dransfield, M. T.
Halpin, D. M. G.
Han, M. K.
Jones, C. E.
Kilbride, S.
Lange, P.
Lomas, D. A.
Martinez, F. J.
Pascoe, S.
Singh, D.
Wise, R. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[2] Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
Day, Nicola C.
Kumar, Subramanya
Criner, Gerard
Dransfield, Mark
Halpin, David M. G.
Han, MeiLan K.
Jones, C. Elaine
Kaisermann, Morrys C.
Kilbride, Sally
Lange, Peter
Lomas, David A.
Martin, Neil
Martinez, Fernando J.
Singh, Dave
Wise, Robert
Lipson, David A.
RESPIRATORY RESEARCH, 2020, 21 (01)
[3] Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
Nicola C. Day
Subramanya Kumar
Gerard Criner
Mark Dransfield
David M. G. Halpin
MeiLan K. Han
C. Elaine Jones
Morrys C. Kaisermann
Sally Kilbride
Peter Lange
David A. Lomas
Neil Martin
Fernando J. Martinez
Dave Singh
Robert Wise
David A. Lipson
Respiratory Research, 21
[4] The IMPACT Trial: Single Inhaler Triple Therapy fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Analysis According to Smoking Status
Halpin, D. M. G.
Bardsley, S.
Criner, G.
Dransfield, M.
Han, M. K.
Jones, C. E.
Kilbride, S.
Lomas, D. A.
Martinez, F.
Pascoe, S.
Singh, D.
Wise, R.
Lipson, D. A.
Lange, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[5] The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: A Pre-Specified Analysis of Safety According to Age
Criner, G. J.
Dransfield, M.
Halpin, D. M. G.
Han, M. K.
Jones, C. E.
Kilbride, S.
Lange, P.
Lomas, D. A.
Martinez, F.
Pascoe, S.
Singh, D.
Wise, R.
Lipson, D. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[6] A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD
Cazzola, Mario
Rogliani, Paola
Calzetta, Luigino
Ora, Josuel
Matera, Maria Gabriella
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (03) : 269 - 283
[7] InforMing the PAthway of COPD Treatment (The IMPACT Study): Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: An Analysis Based on Baseline COPD Medication Use
Singh, D.
Criner, G. J.
Dransfield, M. T.
Halpin, D. M. G.
Han, M. K.
Jones, C. E.
Kilbride, S.
Lange, P.
Lomas, D. A.
Martinez, F. J.
Pascoe, S. J.
Wise, R. A.
Lipson, D. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[8] InforMing the PAthway of COPD Treatment (IMPACT Study)-Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Results Based on an Analysis of the North American Region
Wise, R. A.
Criner, G. J.
Dransfield, M. T.
Han, M. K.
Jones, C. E.
Lettis, S.
Martinez, F. J.
Pascoe, S. J.
Quasny, H.
Lipson, D. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[9] InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis o the Western Europe and North America Regions
Bourdin, Arnaud
Criner, Gerard
Devouassoux, Gilles
Dransfield, Mark
Halpin, David M. G.
Han, MeiLan K.
Jones, C. Elaine
Kalhan, Ravi
Lange, Peter
Lettis, Sally
Lipson, David A.
Lomas, David A.
Maria-Tome, Jose M. Echave-Sustaeta
Martin, Neil
Martinez, Fernando J.
Quasny, Holly
Sail, Lynda
Siler, Thomas M.
Singh, Dave
Thomashow, Byron
Watz, Henrik
Wise, Robert
Hanania, Nicola A.
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2021, 8 (01): : 76 - 90
[10] Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD
Mehta, Rashmi
Pefani, Eleni
Beerahee, Misba
Brealey, Noushin
Barnacle, Helen
Birk, Ruby
Zhu, Chang-Qing
Lipson, David A.
JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (11): : 1461 - 1467

← 1 2 3 4 5 →